Cargando…
The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial
BACKGROUND: Shifts in the gastrointestinal microbiome have been shown to contribute to the progression of metabolic diseases including prediabetes and type 2 diabetes mellitus. Research suggests that in-vivo modulation of the gut microbiome by specific probiotic microorganisms may improve insulin se...
Autores principales: | Palacios, Talia, Vitetta, Luis, Coulson, Samantha, Madigan, Claire D., Denyer, Gareth S., Caterson, Ian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223589/ https://www.ncbi.nlm.nih.gov/pubmed/28069054 http://dx.doi.org/10.1186/s13063-016-1762-x |
Ejemplares similares
-
Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study
por: Palacios, Talia, et al.
Publicado: (2020) -
Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences
por: Vitetta, Luis, et al.
Publicado: (2015) -
The Gastrointestinal Microbiome and Musculoskeletal Diseases: A Beneficial Role for Probiotics and Prebiotics
por: Vitetta, Luis, et al.
Publicado: (2013) -
The Overarching Influence of the Gut Microbiome on End-Organ Function: The Role of Live Probiotic Cultures
por: Vitetta, Luis, et al.
Publicado: (2014) -
Are the Gut Bacteria Telling Us to Eat or Not to Eat? Reviewing the Role of Gut Microbiota in the Etiology, Disease Progression and Treatment of Eating Disorders
por: Lam, Yan Y., et al.
Publicado: (2017)